![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1700029
¼¼°èÀÇ ¼ö¼ú¿ë ½Ç¶õÆ® ¹× Á¢ÂøÁ¦ : Á¦Ç° À¯Çü, Á¦Çü, ÀûÀÀÁõ, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº° ºÐ¼®(-2032³â)Surgical Sealants and Adhesives Market Forecasts to 2032 - Global Analysis By Product Type (Surgical Sealants, Surgical Adhesives and Other Product Types), Form, Indication, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¼ö¼ú¿ë ½Ç¶õÆ® ¹× Á¢ÂøÁ¦ ½ÃÀåÀº 2025³â 36¾ï 1,000¸¸ ´Þ·¯¸¦ Â÷ÁöÇϰí, 2032³â¿¡´Â 81¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGRÀº 12.3%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
¼ö¼ú¿ë ½Ç¶õÆ® ¹× Á¢ÂøÁ¦´Â ¼ö¼ú Áß Á¶Á÷À» °áÇÕÇϰųª ºÀÇÕÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á¿ë ¹°ÁúÀÔ´Ï´Ù. Á¶Á÷ Ç¥¸é »çÀÌÀÇ ¿¬°áÀ» °ÈÇÏ¿© Ä¡À¯¸¦ ÃËÁøÇϰí ÃâÇ÷À» ÁÙÀÌ¸ç »óó ºÀÇÕÀ» µ½½À´Ï´Ù. õ¿¬ ¶Ç´Â ÇÕ¼º ¼ººÐÀ¸·Î ¸¸µé ¼ö ÀÖ´Â ÀÌ·¯ÇÑ Àç·á´Â ´Ù¸ñÀûÀ̸ç Àç°Ç, À§Àå ¹× ½ÉÇ÷°ü ½Ã¼ú¿¡ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
British Journal of Surgery ÀâÁöÀÇ º¸°í¿¡ µû¸£¸é 2020³â 5¿ù Àεµ¿¡¼´Â ¸ÅÁÖ ¾à 48,728°ÇÀÇ ¼ö¼úÀÌ Ãë¼ÒµÇ¾î 12ÁÖ µ¿¾È ¾à 585,000°ÇÀÇ ¼ö¼úÀÌ Ãë¼ÒµÈ °ÍÀ¸·Î Ãß»êµË´Ï´Ù.
¿Ü°ú ¼ö¼úÀÇ Áõ°¡
¿Ü°úÀû ¼ö¼úÀÌ ÀÚÁÖ ÇÊ¿äÇÑ ¾Ï°ú ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÏ´Â °ÍÀÌ ÀÌ·¯ÇÑ Áõ°¡ÀÇ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ´Â »ç¶÷µéÀÌ ¼ö¼úÀÌ ÇÊ¿äÇÑ Áúº´¿¡ ´õ Ãë¾àÇØÁö±â ¶§¹®¿¡ ¼ö¿ä¸¦ Áõ°¡½Ãŵ´Ï´Ù. ȸº¹À» °³¼±Çϰí ÇÕº´ÁõÀ» ³·Ãß´Â ´ú ħ½ÀÀûÀÎ ¼ö¼ú ¹æ¹ýÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ½Ç¶õÆ®¿Í Á¢ÂøÁ¦ÀÇ »ç¿ë·®ÀÌ Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ ¿Ü°úÀû Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ½ÅÈï °æÁ¦±¹ÀÇ ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀÌ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
°í±Þ Á¦Ç°ÀÇ ³ôÀº ºñ¿ë
º¹ÀâÇÑ Á¦Çü, ¾ö°ÝÇÑ Ç°Áú °ü¸®, ±ÔÁ¦ Áؼö ¿ä°ÇÀ¸·Î ÀÎÇØ ƯÈ÷ »ýü ÀûÇÕ¼º ¼ÒÀ糪 ½Å±â¼úÀ» »ç¿ëÇϴ ǰ¸ñÀÇ °æ¿ì Á¦Á¶ ºñ¿ëÀÌ ¸¹ÀÌ µé ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã·´Ü ±â±â´Â Ãʱ⠺ñ¿ëÀÌ ³ô±â ¶§¹®¿¡ ƯÈ÷ ¿¹»êÀÌ ºÎÁ·ÇÑ Áö¿ªÀ̳ª ¼Ò±Ô¸ð ÀÇ·á±â°ü¿¡¼´Â ³Î¸® º¸±ÞµÇÁö ¸øÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ºÀÇջ糪 ½ºÅ×ÀÌÇðú °°Àº ÀüÅëÀûÀÎ »óó ºÀÇÕ ±â¼úÀÇ ºñ¿ëÀÌ Àú·ÅÇϱ⠶§¹®¿¡ º´¿ø°ú Ŭ¸®´Ð¿¡¼´Â ÀÌ·¯ÇÑ Á¡À» °í·ÁÇÏ¿© À̸¦ »ç¿ëÇÏÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ôÀº °¡°ÝÀ¸·Î ÀÎÇØ º¸´Ù È¿À²ÀûÀÎ ÃֽŠ½Ç¶õÆ® ¹× Á¢ÂøÁ¦ÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀ» ÀúÇØÇÒ ¼ö ÀÖÀ¸¸ç, À̴ ƯÈ÷ ÀÇ·á ÀÚ¿øÀÌ ºÎÁ·ÇÑ °³¹ßµµ»ó±¹¿¡¼ ½ÃÀå È®´ë¸¦ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
»óó Ä¡À¯ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
Àü ¼¼°è Àα¸°¡ °í·ÉÈµÇ°í ¸¸¼º Áúȯ°ú ¼ö¼úÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °í±Þ »óó Ä¡À¯ Ä¡·áÀÇ Çʿ伺ÀÌ Á¡Á¡ ´õ Ä¿Áö°í ÀÖ½À´Ï´Ù. ¼ö¼ú¿ë Á¢ÂøÁ¦¿Í ½Ç¶õÆ®´Â ºü¸¥ Ä¡À¯¸¦ ÃËÁøÇÏ°í °¨¿° À§ÇèÀ» ³·Ãß¸ç ¼ö¼ú ÈÄ ÈäÅ͸¦ ÁÙÀÌ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°Àº Á¤Çü¿Ü°ú ¹× ½ÉÇ÷°ü Ä¡·á¿Í °°ÀÌ Á¶Á÷ ºÀÇÕÀÌ Ä¡À¯¿¡ ÇʼöÀûÀÎ º¹ÀâÇÑ ¼ö¼ú¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.
º¹ÀâÇÑ ¿ëµµ ¹× ±³À° ¿ä±¸ »çÇ×
¼ö¼ú À¯Çü°ú °ü·Ã Á¶Á÷¿¡ µû¶ó ÀÌ·¯ÇÑ Á¦Ç°Àº ¿ì¼öÇÑ Á¢Âø·Â, ÁöÇ÷ ¹× Á¶Á÷ ¹ÐºÀÀ» º¸ÀåÇϱâ À§ÇØ Á¤¹ÐÇÑ Àû¿ë ÀýÂ÷°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ¿Ü°úÀÇ¿Í ÀÇ·áÁøÀÌ ÀÌ·¯ÇÑ ±â¼ú¿¡ ´É¼÷ÇØÁö±â À§Çؼ´Â Ưº°ÇÑ ±³À°ÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ µµÀÔ¿¡ ´õ ¿À·£ ½Ã°£ÀÌ °É¸®°í ºñ¿ëµµ ´õ ¸¹ÀÌ µì´Ï´Ù. ¶ÇÇÑ À߸ø »ç¿ëÇÏ¸é °¨¿°À̳ª ºÒÃæºÐÇÑ »óó Ä¡À¯¿Í °°Àº ÇÕº´ÁõÀ» À¯¹ßÇÏ¿© ȯÀÚ °á°ú¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
COVID-19ÀÇ À¯ÇàÀº Àü ¼¼°èÀûÀ¸·Î ÀÀ±Þ Ä¡·á¸¦ ¿ì¼±½ÃÇϰí ÀÚ¿øÀ» Àý¾àÇϱâ À§ÇØ ¼±ÅÃÀû ¼ö¼úÀÌ ¿¬±âµÇ°Å³ª Ãë¼ÒµÇ¸é¼ ¼ö¼ú¿ë ½Ç¶õÆ® ¹× Á¢ÂøÁ¦ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ÇØ´ç Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ ÀϽÃÀûÀ¸·Î °¨¼ÒÇß½À´Ï´Ù. ±×·¯³ª ÀÇ·á ½Ã½ºÅÛÀÌ ÀûÀÀÇÏ°í ºÀ¼â Á¶Ä¡ ÀÌÈÄ ¼ö¼ú·®ÀÌ ¹ÝµîÇÏ¸é¼ ½ÃÀåÀº Á¡ÁøÀûÀΠȸº¹¼¼¸¦ º¸¿´½À´Ï´Ù. ¶ÇÇÑ ÆÒµ¥¹ÍÀº ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±Çϰí ÀÔ¿ø ±â°£À» ÁÙÀÌ´Â µ¥ ÀÖ¾î ½Ç¶õÆ® ¹× Á¢ÂøÁ¦¸¦ Æ÷ÇÔÇÑ Ã·´Ü ¼ö¼ú ¼Ö·ç¼ÇÀÇ Á߿伺À» °Á¶ÇÏ¿© Àå±âÀûÀÎ ¼ºÀå Àü¸ÁÀ» °ßÀÎÇß½À´Ï´Ù.
¼ö¼ú¿ë ½Ç¶õÆ® ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ±Ô¸ð°¡ µÉ Àü¸Á
¼ö¼ú¿ë ½Ç¶õÆ® ºÎ¹®Àº ¸¸¼º ÁúȯÀÇ Áõ°¡¿Í Àα¸ °í·ÉÈ·Î ÀÎÇÑ ¼ö¼ú ÀýÂ÷ÀÇ Áõ°¡·Î ÀÎÇØ ¼ö¿ä¸¦ ÃËÁøÇÏ¿© ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ ¹ßÀü°ú È¿°úÀûÀÎ ÁöÇ÷ ¹× Á¶Á÷ ºÀÇÕ¿¡ ´ëÇÑ Çʿ伺ÀÌ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ »ýü ÀûÇÕ¼º ¼ÒÀç¿Í »ýü ¸ð¹æ ½Ç¶õÆ® ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀº Àû¿ë ºÐ¾ß¿Í ½ÃÀå ¼ºÀåÀ» ´õ¿í È®´ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÁÙÀ̰í ȯÀÚÀÇ È¸º¹ ½Ã°£À» °³¼±ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¸é¼ ÀÌ·¯ÇÑ Á¦Ç°ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
º´¿ø ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ Àü¸Á
¿¹Ãø ±â°£ µ¿¾È º´¿ø ºÎ¹®Àº ¼ö¼ú Áß È¿À²ÀûÀÌ°í ¾ÈÁ¤ÀûÀÎ ÁöÇ÷ ¹× Á¶Á÷ ¹ÐºÀ¿¡ ´ëÇÑ Çʿ伺ÀÌ °¡Àå Áß¿äÇϱ⠶§¹®¿¡ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àα¸ °í·ÉÈ¿Í ¸¸¼º ÁúȯÀ¸·Î ÀÎÇÑ ¼ö¼ú °Ç¼ö Áõ°¡°¡ ¼ö¿ä¸¦ °ßÀÎÇÕ´Ï´Ù. º´¿ø¿¡¼´Â ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÃÖ¼ÒÈÇϰí ȯÀÚÀÇ È¸º¹ ½Ã°£À» ´ÜÃàÇÏ´Â °ÍÀ» ¿ì¼±½ÃÇϱ⠶§¹®¿¡ °í±Þ ½Ç¶õÆ®ÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´¿øÀº Á¾Á¾ ÀÓ»ó ½ÃÇè¿¡ Âü¿©ÇÏ°í »õ·Î¿î ¼ö¼ú ±â¼úÀÇ ¾ó¸® ¾î´äÅͷμ ½ÃÀå µ¿Çâ°ú Á¦Ç° °³¹ß¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀº ºü¸£°Ô Áõ°¡ÇÏ´Â °í·ÉÈ Àα¸¿Í ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¿Ü°ú ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÏ¸é¼ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë¿Í °¡Ã³ºÐ ¼ÒµæÀÇ Áõ°¡´Â ÷´Ü ÀÇ·á Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÇ·á °ü±¤°ú ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ¼ö¿ä´Â ´õ¿í °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í±Þ »óó Ä¡·á ¹× ÁöÇ÷ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀå ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì Áö¿ªÀº ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ ³ôÀº äÅ÷ü·Î ÀÎÇØ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àα¸ °í·ÉÈ¿Í ¸¸¼º Áúȯ À¯º´·ü Áõ°¡´Â ¼ö¼ú ¼ö¿ä¸¦ Áõ°¡½Ãŵ´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº °íǰÁúÀÇ Çõ½ÅÀûÀÎ Á¦Ç°À» º¸ÀåÇÕ´Ï´Ù. ƯÈ÷ »ýü ÀûÇÕ¼º Àç·á¿¡ ´ëÇÑ °·ÂÇÑ R&D ÅõÀÚ¿Í ±â¼ú ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÕ´Ï´Ù.
According to Stratistics MRC, the Global Surgical Sealants and Adhesives Market is accounted for $3.61 billion in 2025 and is expected to reach $8.15 billion by 2032 growing at a CAGR of 12.3% during the forecast period. Surgical sealants and adhesives are medical substances used to bind or seal tissues during surgical procedures. They strengthen the link between tissue surfaces, promoting healing, reducing bleeding, and assisting in wound closure. These materials, which can be made of natural or synthetic components, are versatile and can be used in reconstructive, gastrointestinal, and cardiovascular procedures. While adhesives offer long-lasting tissue connection, sealants frequently serve as barriers to stop fluid leaks.
According to the British Journal of Surgery report, in May 2020, around 48,728 surgical procedures per week were canceled in India, estimating about 585,000 surgical procedures for 12 weeks.
Increasing surgical procedures
The rising incidence of chronic illnesses like cancer and cardiovascular conditions, which frequently call for surgical procedures, is the main cause of this increase. Furthermore, the aging of the world's population increases demand since it makes people more susceptible to illnesses that require surgery. The usage of sealants and adhesives has increased due to advancements in less invasive surgical methods, as they improve recovery and lower complications. Additionally, the market is growing as a result of enhanced access to surgical treatment and increased healthcare spending in emerging economies.
High cost of advanced products
Complex formulations, strict quality controls, and regulatory compliance requirements can make manufacturing these items costly, particularly those that use biocompatible materials or novel technology. These cutting-edge devices' high initial costs frequently prevent them from being widely available, especially in areas with tight budgets or for smaller healthcare practitioners. Due to the lower cost of traditional wound closure techniques like sutures or staples, this consideration may force hospitals and clinics to use them. Furthermore, the high price may discourage the broad use of more recent, efficient sealants and adhesives, which would hinder market expansion, especially in developing nations with limited healthcare resources.
Rising demand for wound healing products
Advanced wound healing treatments are becoming more and more necessary as the world's population ages and the prevalence of chronic illnesses and surgical procedures rises. Surgical adhesives and sealants are essential for encouraging quicker healing, lowering the risk of infection, and decreasing post-operative scarring. These products are particularly helpful in complicated surgeries where tissue sealing is essential for healing, like orthopedic and cardiovascular treatments. Additionally, there is a greater focus on proper wound management as a result of the growing emphasis on improving patient outcomes and lowering healthcare costs, which is driving up demand for surgical sealants and adhesives.
Complex application and training requirements
Depending on the type of surgery and tissue involved, these products frequently require precise application procedures to guarantee good adhesion, hemostasis, and tissue sealing. Adoption takes longer and costs more since surgeons and medical personnel need specific training to become proficient in these techniques. Furthermore, incorrect administration might affect patient outcomes by causing complications like infections or insufficient wound healing. Their widespread usage is made more difficult by the requirement for ongoing education and skill development as well as the variation in product compositions, which restricts market expansion in particular areas.
The COVID-19 pandemic significantly impacted the surgical sealants and adhesives market, as elective surgeries were postponed or canceled globally to prioritize emergency care and conserve resources. This led to a temporary decline in demand for these products. However, the market witnessed a gradual recovery as healthcare systems adapted and surgical volumes rebounded post-lockdowns. The pandemic also highlighted the importance of advanced surgical solutions, including sealants and adhesives, in improving patient outcomes and reducing hospital stays, driving long-term growth prospects.
The surgical sealants segment is expected to be the largest during the forecast period
The surgical sealants segment is expected to account for the largest market share during the forecast period, due to the increasing volume of surgical procedures, driven by a rise in chronic diseases and an aging population, fuels demand. Additionally, advancements in minimally invasive surgeries and the need for effective hemostasis and tissue sealing contribute significantly. Technological innovations, particularly in biocompatible materials and biomimetic sealants, further expand applications and market growth. Furthermore, the focus on reducing post-surgical complications and improving patient recovery times enhances the adoption of these products.
The hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to their need for efficient, reliable hemostasis and tissue sealing during surgeries is paramount. Increased surgical volumes due to aging populations and chronic diseases drive demand. Hospitals prioritize minimizing post-operative complications and reducing patient recovery times, leading to greater adoption of advanced sealants. Furthermore, hospitals often participate in clinical trials and are early adopters of new surgical technologies, influencing market trends and product development.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by rapidly growing aging population and rising prevalence of chronic diseases, increasing surgical procedure volumes. Expanding healthcare infrastructure and rising disposable incomes improve access to advanced medical treatments. Medical tourism and a growing focus on minimally invasive surgeries further accelerate demand. Additionally, increasing awareness about advanced wound care and hemostasis solutions boosts market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to high adoption rates of minimally invasive surgeries. An aging population and rising chronic disease prevalence increase surgical demand. Stringent regulatory standards ensure high-quality, innovative products. Strong R&D investments and technological advancements, particularly in biocompatible materials, propel market growth. Reimbursement policies and a focus on reducing hospital stays also contribute to increased sealant and adhesive usage.
Key players in the market
Some of the key players in Surgical Sealants and Adhesives Market include 3M, Johnson & Johnson, Baxter International, CryoLife, Integra LifeSciences Corporation, Medtronic, Sealantis Ltd., Molnlycke Health Care, Globus Medical, Smith & Nephew, Tissuemed, Vermillion Inc., Asahi Kasei Corporation, TCL Surgical, Stryker Corporation, and Braun Melsungen AG.
In February 2025, Johnson & Johnson MedTech, an emerging leader in neurovascular care, announced today the launch of the CEREGLIDE(TM) 92 Catheter System, a next-generation .092" catheter with the INNERGLIDE(TM) 9 delivery aid, indicated for use in facilitating the insertion and guidance of interventional devices in the neurovascular system.
In December 2024, 3M and US Conec Ltd. announced a strategic licensing agreement for 3M(TM) Expanded Beam Optical Interconnect technology, a solution to meet the performance and scalability needs of next-generation data centers and advanced network architectures. The collaboration combines advanced optical technology from 3M with US Conec's expertise in high-density connectivity systems, expanded beam optics, and precision manufacturing.